catalyst
as of 2026-07-01Vildagliptin for Treatment of Antipsychotic-induced Dyslipidemia — primary completion
at a glance
2025-12-31 · Estimated (est.) — Registry-estimated date, not yet actual.
Synthesized from structured facts only — each point cited above.
Event
What
Vildagliptin for Treatment of Antipsychotic-induced Dyslipidemia — primary completion
Type
Trial Readout
Date
2025-12-31
Date type
ESTIMATED est.
Phase
Phase 2
Registry-estimated date, not yet actual. This date is directional and must not be read as settled.
relationships
The graph out of here